Alaunos Therapeutics Inc (TCRT) Stock Analysis

Alaunos Therapeutics Inc (TCRT) is a publicly traded company in the HEALTHCARE sector. It trades at $2.79, carries a market capitalization of $7.06M. This page summarizes the public market data, fundamentals, and frequently asked questions for TCRT, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Alaunos Therapeutics Inc currently has a Bullish sentiment score of 0.44.

About Alaunos Therapeutics Inc

Alaunos Therapeutics Inc. is a clinical-stage biopharmaceutical company headquartered in Houston, Texas, dedicated to advancing innovative immuno-oncology therapies for cancer treatment. With a strong focus on developing its proprietary T Cell Receptor (TCR) therapy platform, Alaunos aims to harness the power of the immune system to provide effective, targeted therapies for patients with solid tumors. As it continues to progress through clinical trials, the company is positioned to play a sig...

GNG Research Analysis

GNG Research scores Alaunos Therapeutics Inc (TCRT) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for TCRT.

Frequently Asked Questions

Does TCRT pay dividends?

Alaunos Therapeutics Inc (TCRT) does not currently pay a regular dividend.

What is TCRT's market cap?

Alaunos Therapeutics Inc (TCRT) has a market capitalization of $7.06M with a current stock price of $2.79.